(A) Annotation of CITE-seq data on C57BL/6 CD45+CD11b+Ly6G−SiglecF−CD64−MHCII− cells to subpopulations defined in total Syn Ly6c− (CD45+CD11b+Ly6G−SiglecF−CD64−) (Figure 2H).
(B) Expression of TR-MC (Lyve1), DC (CD74), cycling (Top2a), and monocyte (Plac8) subpopulation genes.
(C) Mean ADT intensity of surface markers.
(D) Annotation of scATAC-seq data on C57BL/6 CD45+CD11b+Ly6G−SiglecF−CD64−MHCII− cells to subpopulations defined in total Syn Ly6c− (Figure 2H).
(E and F) (E) Transcription factor (TF) activity and (F) expression of corresponding genes associated with TR-MCs (MafB and MYC), cycling (Fli1), and monocyte (Irf8) subpopulations.
(G) Gating strategy to distinguish intravascular NCMs vs. extravascular DCs and TR-MCs.
(H) NCMs, DCs, and TR-MCs in steady state.